OGI

Organigram Global Inc

Add to Watchlist

Advanced Chart

1.445

+0.035(2.482%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

1.489

Open

1.410

VWAP

1.45

Vol

601.72K

Mkt Cap

193.46M

Low

1.4051

Amount

873.22K

EV/EBITDA(TTM)

Total Shares

103.00M

290.25M

EV/OCF(TTM)

P/S(TTM)

1.05

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

68.04M

+65.72%

43.84M

+6.76%

Estimates Revision

The market is revising Downward the revenue expectations for Organigram Global Inc. (OGI) for FY2025, with the revenue forecasts being adjusted by -0.03% over the past three months. During the same period, the stock price has changed by 22.46%.

Revenue Estimates for FY2025

Revise Downward

-0.03%

In Past 3 Month

Stock Price

Go Up

+22.46%

In Past 3 Month

2 Analyst Rating

38.41% Upside

Wall Street analysts forecast OGI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OGI is 2.00 USD with a low forecast of 1.82 USD and a high forecast of 2.18 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

38.41% Upside

Current: 1.445

Low

1.82

Averages

2.00

High

2.18

38.41% Upside

Current: 1.445

Low

1.82

Averages

2.00

High

2.18

The End

See All Ratings

No Data

Valuation Metrics

The current forward P/E ratio for Organigram Global Inc (OGI.O) is -39.43, compared to its 5-year average forward P/E of -16.75. For a more detailed relative valuation and DCF analysis to assess Organigram Global Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-16.75

Current PE

-39.43

Overvalued PE

-2.00

Undervalued PE

-31.50

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-26.79

Current EV/EBITDA

10.39

Overvalued EV/EBITDA

218.91

Undervalued EV/EBITDA

-272.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

3.28

Current PS

0.92

Overvalued PS

6.31

Undervalued PS

0.24

Financials

Annual

Quarterly

FY2025Q2

YoY :

+74.34%

65.60M

Total Revenue

FY2025Q2

YoY :

-16.29%

-20.41M

Operating Profit

FY2025Q2

YoY :

-256.81%

42.46M

Net Income after Tax

FY2025Q2

YoY :

-206.67%

0.32

EPS - Diluted

FY2025Q2

YoY :

+103.64%

-23.14M

Free Cash Flow

FY2025Q2

YoY :

+1509.43%

8.53

Gross Profit Margin - %

FY2025Q2

YoY :

-50.64%

-13.78

FCF Margin - %

FY2025Q2

YoY :

-189.95%

64.72

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

OGI News & Events

Events Timeline

2025-07-08 (ET)

2025-07-08

06:05:48

Organigram's Collective Project launches e-commerce platform in the U.S.

2025-05-27 (ET)

2025-05-27

06:04:54

Organigram CEO Beena Goldenberg to retire at fiscal year-end

2025-05-12 (ET)

2025-05-12

06:12:49

Organigram reports Q2 revenue $102.8M vs. $57.4M last year

News

3.0

08-01Newsfilter

Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025

5.0

07-08Newsfilter

Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio

5.0

07-08SeekingAlpha

Organigram Global scales US presence, expands hemp-derived THC beverage portfolio